Cargando…
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
BACKGROUND: Cuproptosis, a recently discovered form of cell death, is caused by copper levels exceeding homeostasis thresholds. Although Cu has a potential role in colon adenocarcinoma (COAD), its role in the development of COAD remains unclear. METHODS: In this study, 426 patients with COAD were ex...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957631/ https://www.ncbi.nlm.nih.gov/pubmed/36844874 http://dx.doi.org/10.1155/2023/5925935 |
_version_ | 1784894869256273920 |
---|---|
author | Zhong, Like Zhu, Junfeng Shu, Qi Xu, Gaoqi He, Chaoneng Fang, Luo |
author_facet | Zhong, Like Zhu, Junfeng Shu, Qi Xu, Gaoqi He, Chaoneng Fang, Luo |
author_sort | Zhong, Like |
collection | PubMed |
description | BACKGROUND: Cuproptosis, a recently discovered form of cell death, is caused by copper levels exceeding homeostasis thresholds. Although Cu has a potential role in colon adenocarcinoma (COAD), its role in the development of COAD remains unclear. METHODS: In this study, 426 patients with COAD were extracted from the Cancer Genome Atlas (TCGA) database. The Pearson correlation algorithm was used to identify cuproptosis-related lncRNAs. Using the univariate Cox regression analysis, the least absolute shrinkage and selection operator (LASSO) was used to select cuproptosis-related lncRNAs associated with COAD overall survival (OS). A risk model was established based on the multivariate Cox regression analysis. A nomogram model was used to evaluate the prognostic signature based on the risk model. Finally, mutational burden and sensitivity analyses of chemotherapy drugs were performed for COAD patients in the low- and high-risk groups. RESULT: Ten cuproptosis-related lncRNAs were identified and a novel risk model was constructed. A signature based on ten cuproptosis-related lncRNAs was an independent prognostic predictor for COAD. Mutational burden analysis suggested that patients with high-risk scores had higher mutation frequency and shorter survival. CONCLUSION: Constructing a risk model based on the ten cuproptosis-related lncRNAs could accurately predict the prognosis of COAD patients, providing a fresh perspective for future research on COAD. |
format | Online Article Text |
id | pubmed-9957631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99576312023-02-25 A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma Zhong, Like Zhu, Junfeng Shu, Qi Xu, Gaoqi He, Chaoneng Fang, Luo J Oncol Research Article BACKGROUND: Cuproptosis, a recently discovered form of cell death, is caused by copper levels exceeding homeostasis thresholds. Although Cu has a potential role in colon adenocarcinoma (COAD), its role in the development of COAD remains unclear. METHODS: In this study, 426 patients with COAD were extracted from the Cancer Genome Atlas (TCGA) database. The Pearson correlation algorithm was used to identify cuproptosis-related lncRNAs. Using the univariate Cox regression analysis, the least absolute shrinkage and selection operator (LASSO) was used to select cuproptosis-related lncRNAs associated with COAD overall survival (OS). A risk model was established based on the multivariate Cox regression analysis. A nomogram model was used to evaluate the prognostic signature based on the risk model. Finally, mutational burden and sensitivity analyses of chemotherapy drugs were performed for COAD patients in the low- and high-risk groups. RESULT: Ten cuproptosis-related lncRNAs were identified and a novel risk model was constructed. A signature based on ten cuproptosis-related lncRNAs was an independent prognostic predictor for COAD. Mutational burden analysis suggested that patients with high-risk scores had higher mutation frequency and shorter survival. CONCLUSION: Constructing a risk model based on the ten cuproptosis-related lncRNAs could accurately predict the prognosis of COAD patients, providing a fresh perspective for future research on COAD. Hindawi 2023-02-17 /pmc/articles/PMC9957631/ /pubmed/36844874 http://dx.doi.org/10.1155/2023/5925935 Text en Copyright © 2023 Like Zhong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhong, Like Zhu, Junfeng Shu, Qi Xu, Gaoqi He, Chaoneng Fang, Luo A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma |
title | A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma |
title_full | A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma |
title_fullStr | A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma |
title_full_unstemmed | A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma |
title_short | A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma |
title_sort | prognostic cuproptosis-related lncrna signature for colon adenocarcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957631/ https://www.ncbi.nlm.nih.gov/pubmed/36844874 http://dx.doi.org/10.1155/2023/5925935 |
work_keys_str_mv | AT zhonglike aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT zhujunfeng aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT shuqi aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT xugaoqi aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT hechaoneng aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT fangluo aprognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT zhonglike prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT zhujunfeng prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT shuqi prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT xugaoqi prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT hechaoneng prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma AT fangluo prognosticcuproptosisrelatedlncrnasignatureforcolonadenocarcinoma |